| 000 | 01732 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516172554.0 | ||
| 264 | 0 | _c20140102 | |
| 008 | 201401s 0 0 chi d | ||
| 022 | _a1003-9406 | ||
| 024 | 7 |
_a10.3760/cma.j.issn.1003-9406.2013.05.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGao, Jing | |
| 245 | 0 | 0 |
_a[Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome]. _h[electronic resource] |
| 260 |
_bZhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics _cOct 2013 |
||
| 300 |
_a553-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aCholesterol Ester Transfer Proteins _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeptanoic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCong, Hong-liang | |
| 700 | 1 | _aMao, Yong-min | |
| 700 | 1 | _aLiu, Yi | |
| 700 | 1 | _aZhang, Nan | |
| 700 | 1 | _aChen, Qian | |
| 700 | 1 | _aLiu, Ting | |
| 700 | 1 | _aCui, Rangzhuang | |
| 773 | 0 |
_tZhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics _gvol. 30 _gno. 5 _gp. 553-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3760/cma.j.issn.1003-9406.2013.05.010 _zAvailable from publisher's website |
| 999 |
_c23128295 _d23128295 |
||